Wuhan Wuyao Pharmaceutical is an API manufacturer based in China. It holds 12 valid CEPs across a filed portfolio of 11 molecules. Its GMP standing is certified by EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 7 March 2025 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Huangshi, China | Not on file |
| Huangshi City, China | Not on file |
| China, China | 3010686159 |
| Molecule | Regulators | Docs |
|---|---|---|
| Norepinephrine | EDQM, SFDA (Saudi Arabia) | 3 |
| Epinephrine | EDQM | 2 |
| Metronidazole | EDQM | 2 |
| Dopamine | EDQM | 1 |
| Hydroxychloroquine | EDQM | 1 |
| Isoprenaline | EDQM | 1 |
| Metamizole | EDQM | 1 |
| Norepinephrine Bitartrate | SFDA (Saudi Arabia) | 1 |
| Phenylephrine | EDQM | 1 |
| Trimetazidine Dihydrochloride | EDQM | 1 |
| Xylometazoline | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | None | 1 |
| US FDA | None | 1 |
Choose your molecules and target markets. Wuhan Wuyao Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free